Category: US Healthcare Policy

Telehealth is reshaping US healthcare policy as regulators, payers, and providers weigh how to make virtual care both permanent and equitable. What began as an emergency workaround has evolved into a core delivery channel, creating opportunities to improve access, reduce costs, and support chronic disease management—while raising questions about quality, fraud prevention, and broadband infrastructure. Read more

Telehealth remains a central focus of U.S. healthcare policy as payers, providers, and patients settle into a hybrid care model. Policymakers are navigating how to preserve the access gains telehealth delivered while addressing concerns about quality, fraud, and equitable infrastructure. Understanding the current policy landscape helps stakeholders shape practical, sustainable solutions. Access and equityTelehealth expanded Read more

US healthcare policy is navigating a period of rapid change as policymakers, providers, and payers respond to cost pressure, technology advances, and persistent access gaps. Understanding the key trends shaping decisions today helps stakeholders anticipate how care will be delivered and financed in the years ahead. Telehealth: from emergency tool to regulated mainstreamTelehealth has moved Read more

US healthcare policy is in a state of active evolution as policymakers, providers, and patients push to balance access, affordability, and quality. Several trends are shaping the landscape now: telehealth, prescription drug costs, Medicaid and Medicare changes, and a growing focus on social drivers of health. Understanding where policy is moving helps stakeholders prepare and Read more

U.S. Healthcare Policy: Prescription Drug Pricing Reform and What It Means for Patients Prescription drug pricing continues to be a central focus of U.S. healthcare policy. High out-of-pocket costs, complex rebate systems, and limited transparency have driven policymakers, payers, and patient advocates to push for reforms that improve affordability without undermining innovation. Understanding the policy Read more

Surprise medical bills and price opacity remain among the most urgent frustrations for people navigating US healthcare. Newer federal and state protections have reduced some risks, but patients still face confusing bills, inconsistent disclosures, and hidden out-of-network charges. Knowing your rights and steps to protect yourself can prevent financial shocks and restore control. What the Read more

Surprise medical bills remain one of the most tangible pain points for patients navigating the US healthcare system. When an unexpected out-of-network charge arrives after an emergency visit or a routine procedure that involved an out-of-network specialist, the financial and emotional fallout can be severe. Understanding the protections in place and how disputes get resolved Read more

Telehealth policy is at the center of a major transformation in US healthcare delivery. What began as an emergency-era convenience has become a foundational piece of care strategy for providers, payers, and patients. Policymakers are now balancing access, quality, and cost — shaping rules that will determine how virtual care fits into the health system Read more

Why prescription drug pricing sits at the center of U.S. healthcare policy Prescription drug affordability remains one of the most visible and politically charged issues in U.S. healthcare. High out-of-pocket costs, surprise price spikes, and complex middlemen arrangements have left patients choosing between medications and basic needs. Policymakers are using a mix of legislative, regulatory, Read more

Prescription drug pricing is one of the most visible flashpoints in US healthcare policy, drawing attention from patients, providers, employers, and policymakers. High out-of-pocket costs and complex pricing mechanisms have made medicines unaffordable for many, while stakeholders debate how to balance cost containment with incentives for innovation. What policymakers are pushing nowSeveral policy levers are Read more